XML 85 R65.htm IDEA: XBRL DOCUMENT v3.21.2
Capitalization And Short-Term Borrowings (Schedule Of Share-Based Compensation For Share Awards) (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2019
Performance Shares [Member]      
Schedule of Capitalization [Line Items]      
Number of Shares Outstanding, Beginning of Year 592,628    
Number of Shares Granted 309,470 254,608 244,734
Number of Awards Vested (165,161)    
Number of Shares Forfeited (136,303)    
Number of Shares Outstanding, End of Year 600,634 592,628  
Weighted Average Fair Value per Award, Beginning of Year $ 49.18    
Weighted Average Fair Value per Award Granted 39.19 $ 43.32 $ 55.67
Weighted Average Fair Value per Award Vested 50.99    
Weighted Average Fair Value per Award Forfeited 42.15    
Weighted Average Fair Value per Award, End of Year $ 45.13 $ 49.18  
Stock Appreciation Rights (SARs) [Member]      
Schedule of Capitalization [Line Items]      
Number of Shares Outstanding, Beginning of Year 513,180    
Number of Shares Granted 0 0 0
Number of Shares Exercised 0 0  
Number of Awards Vested 0 0 0
Number of Shares Forfeited 0    
Number of Shares Expired (194,735)    
Number of Shares Outstanding, End of Year 318,445 513,180  
Number of SARs exercisable 318,445    
Weighted Average Exercise Price, Outstanding Beginning of Year $ 56.07    
Weighted Average Exercise Price, Granted 0    
Weighted Average Exercise Price, Exercised 0    
Weighted Average Exercise Price, Forfeited 0    
Weighted Average Exercise Price, Expired 60.10    
Weighted Average Exercise Price, Outstanding End of Year 53.60 $ 56.07  
Weighted Average Exercise Price, SARs exercisable $ 53.60    
Weighted Average Remaining Contractual Life, Outstanding 10 months 24 days    
Weighted Average Remaining Contractual Life, SARs exercisable 10 months 24 days    
Aggregate Intrinsic Value Outstanding $ 0    
Aggregate Intrinsic Value, SARs exercisable $ 0